Members of the Division of Cell Matrix Biology and Regenerative Medicine address fundamental questions in regenerative medicine, stem cell biology and the role of extracellular matrix in the building and repair of tissues.
Our research ranges from the mechanisms underpinning cell interactions with matrix in tissues, to understanding tissue development, stem cell biology and regeneration, through to clinical application, developing engineered tissues and delivering novel cell and gene therapies for patient benefit.
The work is multidisciplinary and collaborative, involving research into many different organs and tissues. Our research uses state of the art, enabling technologies such as super-resolution imaging, electron microscopy, genomics, proteomics, genome editing, nanomedicine, cell and gene therapies, including engineering and materials solutions.
Extracellular matrix is essential for multicellular animal life. It surrounds and supports cells and accounts for the majority of our body mass.
Dysregulation of matrix is a central process in the pathogenesis of major human chronic diseases affecting the cardiovascular system, the kidney, and musculoskeletal tissues, is a feature of multisystem cancers, and is a critical factor in fibrosis. Using new insight gained through multidisciplinary approaches and collaborative interactions between research groups, our aim is to understand the regulation of matrix in health and its dysregulation in disease.
Wellcome Trust Centre for Cell-Matrix Research (WTCCMR)
The Wellcome Trust Centre for Cell-Matrix Research is an interdisciplinary research centre based at The University of Manchester. Established in 1995, the Centre was successfully renewed in 2016, bringing together principal investigators from the Division with others from across the Faculty.
Stem cell biology
The development of therapies using embryonic or adult stem cells requires a fundamental understanding of the developmental process.
Scientists in our division seek to understand new molecular pathways regulating pluripotent stem cells using ’omics technologies.
Others are seeking to apply human adult (musculoskeletal, neural and haematopoietic) and pluripotent (embryonic and induced pluripotent) stem cells to therapies in patients with disease and to produce in vitro disease models to generate novel repair-therapeutics.
Regenerative medicine builds upon our understanding of the basic mechanisms in cell and developmental biology with the ultimate aim of translating this knowledge to improve the repair, replacement or regeneration of damaged tissues and organs following disease, injury or ageing.
Our strengths span bioengineering, biomaterials and tissue engineering, stem cells, developmental biology, cell-matrix biology, inflammation, wound healing and cell/gene therapies.
Our internationally leading themes that address unmet clinical needs include:
- regenerating musculoskeletal tissues;
- developing stem cell gene therapies for inherited genetic diseases;
- renal tract regeneration;
- developing therapies for nerve repair;
- regulating inflammatory responses in tissue repair;
- disease modelling for drug and therapeutic development;
- enhancing chronic wound healing.
Manchester Regenerative Medicine Network
The Manchester Regenerative Medicine Network is a cross-faculty multidisciplinary network at The University of Manchester. It brings together biologists, material scientists, bioengineers and clinicians with an interest in regenerative medicine aiming to repair, replace or regenerate damaged tissues, using cell or gene therapy and tissue engineering.
Head of division
Professor Judith Hoyland
View a list of researchers in the division
Professor Judith Hoyland
tel: +44 (0)161 275 5425